TCBIO
Get informed when a big investor buys or sells
+ FollowUndervalued by 888% based on the discounted cash flow analysis.
| Market cap | $797.27 Million |
|---|---|
| Enterprise Value | $-30,982,551,126.00 |
| Dividend Yield | $1.44 (0.45%) |
| Earnings per Share | $6.86 |
| Beta | 0.67 |
| Outstanding Shares | 43,614,271 |
| P/E Ratio | 11.47 |
|---|---|
| PEG | 95.53 |
| Price to Sales | 0.43 |
| Price to Book Ratio | 0.22 |
| Enterprise Value to Revenue | -14.66 |
| Enterprise Value to EBIT | -49.6 |
| Enterprise Value to Net Income | -86 |
| Total Debt to Enterprise | 1.01 |
| Debt to Equity | -7.7 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data